BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 23256043)

  • 1. KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands.
    Farcas AM; Blackledge NP; Sudbery I; Long HK; McGouran JF; Rose NR; Lee S; Sims D; Cerase A; Sheahan TW; Koseki H; Brockdorff N; Ponting CP; Kessler BM; Klose RJ
    Elife; 2012 Dec; 1():e00205. PubMed ID: 23256043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes.
    He J; Shen L; Wan M; Taranova O; Wu H; Zhang Y
    Nat Cell Biol; 2013 Apr; 15(4):373-84. PubMed ID: 23502314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FBXL10/KDM2B scaffolding protein associates with novel polycomb repressive complex-1 to regulate adipogenesis.
    Inagaki T; Iwasaki S; Matsumura Y; Kawamura T; Tanaka T; Abe Y; Yamasaki A; Tsurutani Y; Yoshida A; Chikaoka Y; Nakamura K; Magoori K; Nakaki R; Osborne TF; Fukami K; Aburatani H; Kodama T; Sakai J
    J Biol Chem; 2015 Feb; 290(7):4163-77. PubMed ID: 25533466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and polycomb domain formation.
    Blackledge NP; Farcas AM; Kondo T; King HW; McGouran JF; Hanssen LLP; Ito S; Cooper S; Kondo K; Koseki Y; Ishikura T; Long HK; Sheahan TW; Brockdorff N; Kessler BM; Koseki H; Klose RJ
    Cell; 2014 Jun; 157(6):1445-1459. PubMed ID: 24856970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kdm2b Regulates Somatic Reprogramming through Variant PRC1 Complex-Dependent Function.
    Zhou Z; Yang X; He J; Liu J; Wu F; Yu S; Liu Y; Lin R; Liu H; Cui Y; Zhou C; Wang X; Wu J; Cao S; Guo L; Lin L; Wang T; Peng X; Qiang B; Hutchins AP; Pei D; Chen J
    Cell Rep; 2017 Nov; 21(8):2160-2170. PubMed ID: 29166607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fbxl10/Kdm2b recruits polycomb repressive complex 1 to CpG islands and regulates H2A ubiquitylation.
    Wu X; Johansen JV; Helin K
    Mol Cell; 2013 Mar; 49(6):1134-46. PubMed ID: 23395003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis.
    Isshiki Y; Nakajima-Takagi Y; Oshima M; Aoyama K; Rizk M; Kurosawa S; Saraya A; Kondo T; Sakaida E; Nakaseko C; Yokote K; Koseki H; Iwama A
    Blood Adv; 2019 Sep; 3(17):2537-2549. PubMed ID: 31471323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KDM2B is involved in the epigenetic regulation of TGF-β-induced epithelial-mesenchymal transition in lung and pancreatic cancer cell lines.
    Wanna-Udom S; Terashima M; Suphakhong K; Ishimura A; Takino T; Suzuki T
    J Biol Chem; 2021; 296():100213. PubMed ID: 33779563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycomb complex recruitment in pluripotent stem cells.
    Barrero MJ; Izpisua Belmonte JC
    Nat Cell Biol; 2013 Apr; 15(4):348-50. PubMed ID: 23548929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Structural Elements of the Lysine Specific Demethylase 2B CxxC Domain Associated with Replicative Senescence Bypass in Primary Mouse Cells.
    Deiktakis EE; Abrams M; Tsapara A; Stournaras C; Tsatsanis C; Tsichlis PN; Kampranis SC
    Protein J; 2020 Jun; 39(3):232-239. PubMed ID: 32270414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KDM2 proteins constrain transcription from CpG island gene promoters independently of their histone demethylase activity.
    Turberfield AH; Kondo T; Nakayama M; Koseki Y; King HW; Koseki H; Klose RJ
    Nucleic Acids Res; 2019 Sep; 47(17):9005-9023. PubMed ID: 31363749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two competing mechanisms of DNMT3A recruitment regulate the dynamics of de novo DNA methylation at PRC1-targeted CpG islands.
    Weinberg DN; Rosenbaum P; Chen X; Barrows D; Horth C; Marunde MR; Popova IK; Gillespie ZB; Keogh MC; Lu C; Majewski J; Allis CD
    Nat Genet; 2021 Jun; 53(6):794-800. PubMed ID: 33986537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.
    Tzatsos A; Paskaleva P; Ferrari F; Deshpande V; Stoykova S; Contino G; Wong KK; Lan F; Trojer P; Park PJ; Bardeesy N
    J Clin Invest; 2013 Feb; 123(2):727-39. PubMed ID: 23321669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells.
    Kottakis F; Foltopoulou P; Sanidas I; Keller P; Wronski A; Dake BT; Ezell SA; Shen Z; Naber SP; Hinds PW; McNiel E; Kuperwasser C; Tsichlis PN
    Cancer Res; 2014 Jul; 74(14):3935-46. PubMed ID: 24853546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing.
    Kang JY; Kim JY; Kim KB; Park JW; Cho H; Hahm JY; Chae YC; Kim D; Kook H; Rhee S; Ha NC; Seo SB
    FASEB J; 2018 Oct; 32(10):5737-5750. PubMed ID: 29763382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PR-DUB safeguards Polycomb repression through H2AK119ub1 restriction.
    Li R; Huang D; Zhao Y; Yuan Y; Sun X; Dai Z; Huo D; Liu X; Helin K; Li MJ; Wu X
    Cell Prolif; 2023 Oct; 56(10):e13457. PubMed ID: 36959757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KDM2B/FBXL10 targets c-Fos for ubiquitylation and degradation in response to mitogenic stimulation.
    Han XR; Zha Z; Yuan HX; Feng X; Xia YK; Lei QY; Guan KL; Xiong Y
    Oncogene; 2016 Aug; 35(32):4179-90. PubMed ID: 26725323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXL10 protects Polycomb-bound genes from hypermethylation.
    Boulard M; Edwards JR; Bestor TH
    Nat Genet; 2015 May; 47(5):479-85. PubMed ID: 25848754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma.
    Banito A; Li X; Laporte AN; Roe JS; Sanchez-Vega F; Huang CH; Dancsok AR; Hatzi K; Chen CC; Tschaharganeh DF; Chandwani R; Tasdemir N; Jones KB; Capecchi MR; Vakoc CR; Schultz N; Ladanyi M; Nielsen TO; Lowe SW
    Cancer Cell; 2018 Mar; 33(3):527-541.e8. PubMed ID: 29502955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interdependence of PRC1 and PRC2 for recruitment to Polycomb Response Elements.
    Kahn TG; Dorafshan E; Schultheis D; Zare A; Stenberg P; Reim I; Pirrotta V; Schwartz YB
    Nucleic Acids Res; 2016 Dec; 44(21):10132-10149. PubMed ID: 27557709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.